Kanada - Kiingereza - Health Canada

sandoz canada incorporated - darunavir - tablet - 800mg - darunavir 800mg - hiv protease inhibitors

Marekani - Kiingereza - NLM (National Library of Medicine)

janssen products lp - darunavir (unii: yo603y8113) (darunavir - unii:yo603y8113), cobicistat (unii: lw2e03m5pg) (cobicistat - unii:lw2e03m5pg), emtricitabine (unii: g70b4etf4s) (emtricitabine - unii:g70b4etf4s), tenofovir alafenamide (unii: el9943ag5j) (tenofovir anhydrous - unii:w4hfe001u5) - symtuza is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and pediatric patients weighing at least 40 kg: - who have no prior antiretroviral treatment history or - who are virologically suppressed (hiv-1 rna less than 50 copies per ml) on a stable antiretroviral regimen for at least 6 months and have no known substitutions associated with resistance to darunavir or tenofovir. darunavir and cobicistat are both inhibitors of the cytochrome p450 3a (cyp3a) isoform. symtuza should not be co-administered with medicinal products that are highly dependent on cyp3a for clearance and for which increased plasma concentrations are associated with serious and/or life-threatening events (narrow therapeutic index). darunavir and cobicistat are both substrates of the cytochrome p450 3a (cyp3a) isoform. co-administration of symtuza with cyp3a inducers is expected to lower plasma concentrations of darunavir and cobicistat which may lead to loss of efficacy

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - darunavir 75 mg - film-coated tablet - 75 mg - darunavir 75 mg - darunavir

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - darunavir 150 mg - film-coated tablet - 150 mg - darunavir 150 mg - darunavir

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - darunavir 300 mg - film-coated tablet - 300 mg - darunavir 300 mg - darunavir

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - darunavir 400 mg - film-coated tablet - 400 mg - darunavir 400 mg - darunavir

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - darunavir 600 mg - film-coated tablet - 600 mg - darunavir 600 mg - darunavir

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - darunavir 800 mg - film-coated tablet - 800 mg - darunavir 800 mg - darunavir

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - darunavir 150 mg - film-coated tablet - 150 mg - darunavir 150 mg - darunavir

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - darunavir 75 mg - film-coated tablet - 75 mg - darunavir 75 mg - darunavir